Immuni Therapeutics opens EUR 2m funding round to develop a vaccine against viral infections
Immuni Therapeutics abre una ronda de financiación de EUR 2m para desarrollar una vacuna contra infecciones víricas
Intel ID : 299493
|
||||
| Intel ID | 299493 | ||
| Value | EUR 2,00m | ||
| Native Currency | Euro (EUR) | ||
| Date |
 |
||
| Country |  |
||
| Geography | |
||
| Subsector (Old TTR Sectors) |
|
||
| Type |
|
||
| Intel Grade |
|
||
| Source |
|
||
| Tags | |
Target
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Country |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.